Patents by Inventor GTx, Inc.

GTx, Inc. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20130197049
    Abstract: The present invention relates to novel compounds having anti-cancer activity, methods of making these compounds, and their use for treating cancer and drug-resistant tumors, e.g. melanoma, metastatic melanoma, drug resistant melanoma, prostate cancer and drug resistant prostate cancer.
    Type: Application
    Filed: November 14, 2012
    Publication date: August 1, 2013
    Applicants: UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION, GTx, Inc.
    Inventors: GTx, Inc., University Of Tennessee Research Foundation
  • Publication number: 20130150403
    Abstract: The present application relates to methods of treating, preventing, delaying the onset of, reducing the incidence of, or reducing the severity of hypertension and of a condition associated with cardiovascular disease
    Type: Application
    Filed: October 15, 2012
    Publication date: June 13, 2013
    Applicants: VA Long Beach Healthcare System, GTx, Inc.
    Inventors: GTx, Inc., VA Long Beach Healthcare System
  • Publication number: 20130122085
    Abstract: This invention provides a pharmaceutical composition comprising Compound I-V, including inter alia solid dosage forms of powder-filled capsule formulations, liquid-filled softgel capsules (softgels), tablets, and sustained release dosage forms, and uses thereof in treating a variety of diseases or conditions in a subject, for example, treating a muscle wasting disease and/or disorder, a bone related disease and/or disorder, metabolic syndrome, diabetes and associated diseases, and others.
    Type: Application
    Filed: November 1, 2012
    Publication date: May 16, 2013
    Applicant: GTx, Inc.
    Inventor: GTx, Inc.